Osteoarthritis (OA) is a leading cause of disability and affects millions of people around the world. In fact, as of 2019, it’s estimated that about 528 million people were living with OA. The condition happens when the cartilage in joints breaks down, leading to pain, stiffness, and discomfort. Most treatments focus on managing pain and helping people maintain joint function, with viscosupplements like hyaluronan becoming popular.

Hymovis is a special type of hyaluronan designed to ease knee pain caused by OA. It works by mimicking the natural fluid in the joints, providing cushioning and lubrication to make movement more comfortable. This makes it a great option for those looking for relief from OA symptoms.

In this article, we’ll explore Hymovis’s generic name, how it works, and its benefits to help you understand this effective viscosupplement treatment.

Key Takeaways

  • Hymovis is a hyaluronic acid-based treatment specifically designed for knee osteoarthritis, providing cushioning and lubrication to the joint.
  • It uses high-molecular-weight viscoelastic hyaluronan, which makes it thicker and more elastic compared to other hyaluronic acid treatments.
  • Hymovis offers long-lasting relief by staying in the joint longer, reducing the need for frequent injections.
  • The treatment helps reduce pain, improve mobility, and enhance overall joint function for up to six months.
  • Hymovis is an excellent option for those who haven’t found relief from simpler osteoarthritis treatments.

About: Medical Spa RX provides medical practices with premium products at the best prices. If you’re looking to buy Hymovis for your practice, the sales representatives at Medical Spa RX can give you guidance.

What is Hymovis?

Knee injection.

Hymovis is a specialized treatment for knee pain caused by osteoarthritis. It uses ultra-pure hyaluronan, which has been modified uniquely without any added chemicals. Hyaluronan, a substance naturally found in our bodies, acts as a lubricant and cushion for the joints, helping them move smoothly and reducing friction.

Hymovis is typically recommended for people with osteoarthritis who haven’t had success with simpler treatments. The injections are administered directly into the knee using a single-use syringe to ensure safety and cleanliness.

Many patients often compare Hymovis vs Euflexxa when choosing a viscosupplement, as both offer pain relief, but Hymovis is known for its unique composition and longer-lasting effects.

The Active Ingredient

Knee injection.

What sets Hymovis apart is its use of high-molecular-weight viscoelastic hyaluronan. This particular form of hyaluronic acid is not only thicker but also more elastic, allowing it to stretch and move within the knee joint. Thanks to a unique process that doesn’t involve adding chemicals, Hymovis stays in the joint longer, providing more extended relief for people with osteoarthritis.

Unlike other hyaluronic acid treatments, which might break down faster or offer shorter-term results, Hymovis’s thicker and more durable formula provides better cushioning and lubrication over a longer period.

The Unique Properties of High Molecular Weight Hyaluronan

Knee injection.

The high-molecular-weight hyaluronan in Hymovis provides joint lubrication and reduces pain. Think of it like adding oil to a squeaky door hinge—this thicker, elastic form of hyaluronic acid acts as both a lubricant and shock absorber for the knee. By helping the joint move more smoothly, Hymovis reduces the pain commonly associated with osteoarthritis.

Beyond just pain relief, Hymovis also improves mobility. Many osteoarthritis patients struggle with stiffness and difficulty moving. Still, the high molecular weight of the hyaluronan in Hymovis mimics the body’s natural joint fluid, making movement more manageable and more comfortable.

The Molecular Structure of Hymovis and Its Long-Lasting Effects

What makes Hymovis stand out is its unique molecular structure. Its high-molecular-weight hyaluronan is thicker and more elastic, allowing it to extend its pain relief effects for patients battling osteoarthritis. The elasticity also helps it act like a cushion, reducing friction between bones and easing discomfort during movement.

In comparison, lower molecular weight hyaluronic acid breaks down more quickly in the body, meaning patients may need more frequent injections to maintain relief. Hymovis, with its enhanced durability, reduces the need for frequent treatments, making it a convenient option for long-lasting pain management.

Conclusion

Hymovis offers a promising solution for those dealing with knee pain caused by osteoarthritis. Its key ingredient, high-molecular-weight viscoelastic hyaluronan, sets it apart by providing enhanced joint lubrication and lasting pain relief.

What makes Hymovis unique is its ability to stay in the joint longer, offering extended relief compared to other treatments. For people with knee osteoarthritis, it’s a highly effective option to reduce pain and improve mobility, giving them a better quality of life.

FAQs

1. How does Hymovis differ from other hyaluronic acid treatments?

Hymovis uses high-molecular-weight hyaluronan, making it thicker and more elastic than other treatments. This allows it to stay in the joint longer, providing extended pain relief.

2. How long do the effects of Hymovis last?

The effects of Hymovis can last up to six months, offering long-lasting relief from knee osteoarthritis symptoms.

3. Are there any side effects of Hymovis injections?

Common side effects include mild swelling or discomfort at the injection site, but these usually subside within a few days.

4. Who is a good candidate for Hymovis?

Hymovis is ideal for individuals with knee osteoarthritis who haven’t found sufficient relief from other treatments, such as pain medications or physical therapy.

schedule a meeting with sales representative MedicalSpaRX
Need help or additional information?

Our sales representatives are here for you!

SCHEDULE A MEETING

References

World Health Organization. Osteoarthritis. Published July 14, 2023. https://www.who.int/news-room/fact-sheets/detail/osteoarthritis

Marques, C. L., Pinto, D., & Ribeiro, P. (2023). Viscosupplementation for knee osteoarthritis: A comprehensive systematic review. The Bone & Joint Journal, 106-B(6), 769-780. https://doi.org/10.1302/0301-620X.106B6.BJJ-2023-1272.R1